MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance - Wikidata - wikimedia - TriplyDB

MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance

MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance

http://www.wikidata.org/entity/Q28286950

about

Recent advances in the molecular understanding of glioblastoma A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets The MiRNA Journey from Theory to Practice as a CNS Biomarker MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.The role of microRNAs in glioma initiation and progression.Significance of miR-196b in tumor-related epilepsy of patients with gliomas.Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas.Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes.OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.miR-196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas.Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype.MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.Epigenetic alteration and microRNA dysregulation in cancer MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.MiR-328 expression is decreased in high-grade gliomas and is associated with worse survival in primary glioblastoma.Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference.Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma.Therapy-, gender- and race-specific microRNA markers, target genes and networks related to glioblastoma recurrence and survival.Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells.High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.Identification of low miR-105 expression as a novel poor prognostic predictor for human glioma.MiR-135a and MRP1 play pivotal roles in the selective lethality of phenethyl isothiocyanate to malignant glioma cells.Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma.Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma Role of MicroRNAs in Malignant Glioma MiR-106a is an independent prognostic marker in patients with glioblastoma.Network analysis of microRNAs, transcription factors, target genes and host genes in human anaplastic astrocytoma.

P2860

Q24632928-1A3ED8FB-4CF6-4FE6-823F-BFBCE47DD414 Q24633772-9A1BD971-16F6-4F76-9E15-03A4AC1F307F Q26747273-7F190DAA-BC93-4698-93F9-095F77F7906D Q26765758-5A0F95B2-55EF-4E22-9316-D263FBEBDC1A Q26767457-8E1EB545-0090-41FA-BAD5-02A6F1849968 Q26865287-4BAD14FE-2934-4B8C-843E-C0902060E53F Q30414321-0F0AC4E7-A9D4-467D-9510-07D5834C8181 Q30428370-43634D0F-3C0B-44FE-AC7E-8A0B4B48691A Q31104534-CFF53F7F-3E50-411B-9DDC-80D6445E44CC Q33580714-65CAF43C-43F6-4975-858F-F117F1B8DE95 Q33925544-311C506A-AB4D-4149-A81A-DE97A73A4849 Q33926927-4F4A7EE6-CD5D-449D-9E8E-8685A5F1DE7D Q34252160-CA1C1E74-EE22-428B-AAED-FCE0D70A6B61 Q34279430-C1C9AEF1-31C0-4E7E-8511-58509FF067AD Q34310702-8D69AEF0-B4E7-479D-BE54-898F9F058B17 Q34313824-9E4B9F19-6E24-464D-80D2-A97EB4B5F145 Q34372870-E62A50F8-8C7D-4045-937D-B502EA9A5210 Q34392645-3A235A80-6FAA-4194-94D1-0113E32B6F1C Q34409620-0B488016-8581-4F4A-AEFC-33B584926199 Q34450679-4D0162A8-4D34-42A4-BAB1-CAD79DBAFA8B Q34576376-F3054F6A-B9D2-45C8-879D-6550E8373CA4 Q34727926-46192907-6904-44C0-8EFB-F5F19F5A8D7D Q35127713-F15BAA4C-AF43-4205-B15F-C0B940137644 Q35145265-83BC0924-1D35-4EF4-9566-00E9B14FE7D7 Q35149598-358AD674-E7A9-44B7-82E4-38480578D915 Q35633805-E17E216A-5622-4340-A84A-6EB8145FA739 Q35854013-D26B59FD-16BE-4800-8A39-3BDD4AD2163F Q35857777-8BCAEA8B-3F01-4A83-84EF-C0DE8B1AE446 Q35876143-559881A5-BA7A-40A7-9A32-32F0534C54E5 Q35883569-7078FCB9-BEAF-4C67-AE76-EB45446E627C Q35919049-A683293F-22CF-4C97-9A89-EC08CCDC73D2 Q36046299-7F9BC10E-E675-4C48-B531-A4D4761930A5 Q36050048-22FEEC5E-A6C8-4C74-8F82-56E631DCD298 Q36179175-A3825778-82F2-48C0-84FA-90F543338E73 Q36268697-F299B520-2694-47FC-8AC6-832D9DB75D65 Q36557234-5EC2A2E9-6D94-448A-BBAE-B6DAA7624BFD Q36608190-48FC75D9-E7D2-44CF-A70A-EEB174D24402 Q36797902-CB84C60E-B6C4-4129-953B-F7A9C3CC1574 Q36865988-0216E223-3195-48E9-BC8B-EC9CE2139D55 Q37001046-A0AF24C9-0BA3-4C42-A3C3-F1FFC534CA24

P2860

MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance

http://www.wikidata.org/entity/Q28286950

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

MiRNA-196 is upregulated in gl ...... nd has prognostic significance

@ast

MiRNA-196 is upregulated in gl ...... nd has prognostic significance

@en

MiRNA-196 is upregulated in gl ...... nd has prognostic significance

@nl

type

label

MiRNA-196 is upregulated in gl ...... nd has prognostic significance

@ast

MiRNA-196 is upregulated in gl ...... nd has prognostic significance

@en

MiRNA-196 is upregulated in gl ...... nd has prognostic significance

@nl

prefLabel

MiRNA-196 is upregulated in gl ...... nd has prognostic significance

@ast

MiRNA-196 is upregulated in gl ...... nd has prognostic significance

@en

MiRNA-196 is upregulated in gl ...... nd has prognostic significance

@nl

P1433

Q28286950-99EB3EAE-B726-4831-8406-595CD4B6AB63

P1476

Q28286950-ABD62E51-82B6-4C83-A4A1-D585781BABC1

P2093

Q28286950-0812F7F7-1016-4789-AE04-0E0CDC52CC85

Q28286950-196E2ED4-3A98-4F69-A5BF-A5B0750F3749

Q28286950-329A9D2D-E817-43E7-BBCF-3B95E1A143FC

Q28286950-35B19FFC-AF99-4980-BE8F-6464E3E34D12

Q28286950-69B8C6F7-A2E2-428E-98B4-E3D17EF92296

Q28286950-84E53891-39BF-4B29-A6C6-9AE0E3101F7E

Q28286950-99CB2D50-8E1C-40CB-9D26-457CC5B8BD4F

Q28286950-9B0956E7-2EE0-425D-82F0-BB354BDEC7EE

Q28286950-A30E45EC-2509-415E-BEFB-CB8D805E1CFC

Q28286950-C1D3CA08-0568-487E-80A0-1720F66469CC

P304

Q28286950-8F739DB8-6DC3-40C9-9950-FACD234639B4

P31

Q28286950-56C44BCA-7BAE-423A-B750-249B1D3C8697

P3181

Q28286950-BEFDAB80-F1BD-4DA2-B74C-3238EDE29A67

P356

Q28286950-9B26E437-AEBF-406D-8525-DDAA46CB26D0

P407

Q28286950-0F584566-EEBB-48D3-9472-E6F3680D114C

P433

Q28286950-DE8A4DD6-F2D1-487C-9840-3F2A35ED40CC

P478

Q28286950-50EC6095-ED13-4EF0-B6C5-1E46B35BA47F

P50

Q28286950-5C939147-CDE6-4E7F-BD0E-29F8EC552A91

P577

Q28286950-5E85094E-021F-4645-BC10-1AA9FFC59724

P5875

Q28286950-522CCBE6-A88B-4996-A2EA-D5CE22534EFA

P698

Q28286950-8C555334-D94B-4A63-9182-5926B26A48BB

P3181

P356

1078-0432.CCR-10-0207

P1433

Clinical Cancer Research

P1476

MiRNA-196 is upregulated in gl ...... nd has prognostic significance

@en

P2093

Akira Nakamizo

http://www.w3.org/2001/XMLSchema#string

Daisuke Kuga

http://www.w3.org/2001/XMLSchema#string

Kenshi Hayashi

http://www.w3.org/2001/XMLSchema#string

Koji Yoshimoto

http://www.w3.org/2001/XMLSchema#string

Masahiro Mizoguchi

http://www.w3.org/2001/XMLSchema#string

Satoshi O Suzuki

http://www.w3.org/2001/XMLSchema#string

Tadahisa Shono

http://www.w3.org/2001/XMLSchema#string

Tomio Sasaki

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Amano

http://www.w3.org/2001/XMLSchema#string

Xinlong Ma

http://www.w3.org/2001/XMLSchema#string

P304

4289-4297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1330182

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-10-0207

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45092554

http://www.w3.org/2001/XMLSchema#string

P698

20601442

http://www.w3.org/2001/XMLSchema#string